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Dexmedetomidine-induced Pyrexia
Brian Mason MD, Stanlies D’Souza MD
Department of Anesthesiology at Baystate Medical Center / University of Massachusetts Medical School

INTRODUCTION
I am pleased to present a case highlighting a rare complication of dexmedetomidine and
describing: (1). Its relationship to the administration of dexmedetomidine; (2). A possible
mechanism for dexmedetomidine-induced fever; and (3). Management of
dexmedetomidine-induced fever in a critical care setting.

CONCLUSION
CASE HISTORY
A 79-year-old male with incarcerated umbilical hernia, afebrile and on broad spectrum
antibiotics, underwent a right hemicolectomy for incarcerated inguinal hernia. Following
uneventful surgery, the patient was transferred to ICU for postoperative management.
Intravenous dexmedetomidine infusion (1mg/kg bolus followed by 0.4 mcg/kg/hr) was
started for postoperative agitation. However, shortly after starting the infusion, the patient
became febrile to 105.8° by esophageal temperature. Dexmedetomidine infusion was
discontinued, one (1) gram of intravenous acetaminophen was given, and a cooling blanket
was applied; the fever subsequently decreased with complete resolution to normal baseline
at six hours.

DISCUSSION
Dexmedetomidine’s primary site of action is the Locus Coeruleus, the major
noradrenergic nucleus of the brain that communicates with a wide subset of neural
structures and plays a central role in a number of physiologic functions.1 The primary
effect of dexmedetomidine on the Locus Coeruleus is regulation of arousal, making it a
common choice for sedation in the ICU. Recently, however, it has been found to play a
role in the control of autonomic function1 with the rare side effect of pyrexia. Nuclei in the
Caudal Raphe Magnus are involved in thermoregulation, causing increases in body
temperature secondary to direct stimulation from the Locus Coeruleus.1
Dexmedetomidine has been implicated in a small but growing number of case reports of
drug-induced fever as a rare side effect.2 In our case, after starting dexmedetomidine
according to our institutional standards and established critical care guidelines3, an
extreme fever was noted; dexmedetomidine was immediately suspect due to the timing of
the fever and lack of other readily identifiable causes, therefore it was immediately
discontinued and the fever treated.

Dexmedetomidine-induced fever is a rare side effect that clinicians should be
aware of, especially in the ICU setting, where it is a common choice for
sedation. Since there are so few documented cases and the fever can
manifest at varying time intervals2, dexmedetomidine fever should be
considered in the differential diagnosis for fever for any patient receiving it for
sedation. One possible explanation for the mechanism of fever is via direct
stimulation of areas of the brain responsible for thermoregulation, such as the
Caudal Raphe Magnus by the Locus Coeruleus.1 The Locus Coeruleus, as
the primary site of action of Dexmedetomidine, is implicated in many
important physiologic functions, although why some patients develop fever
and others do not is not understood.2 Diagnosis of dexmedetomidineinduced drug fever should be treated immediately, since body temperature
can become severely elevated. As with other cases of drug fever, the
offending agent should be discontinued and active cooling measures
initiated. IV acetaminophen and cooling blankets can be employed and other
causes of fever must be considered since dexmedetomidine-induced fever is
a diagnosis of exclusion.
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